Dashboard
Manage Tickers

CYTHCyclo Therapeutics, Inc.

Nasdaq cyclotherapeutics.com


$ 1.47 $ -0.01 (-0.68 %)    

Wednesday, 01-May-2024 14:50:41 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 427.08 $ 1.84 (0.43 %)
DIA $ 382.31 $ 3.42 (0.9 %)
SPY $ 505.01 $ 0.61 (0.12 %)
TLT $ 88.87 $ 0.31 (0.35 %)
GLD $ 213.12 $ -0.67 (-0.31 %)
$ 1.45
$ 1.57
$ 0.00 x 0
$ 0.00 x 0
$ 1.47 - $ 1.57
$ 0.89 - $ 2.57
29,137
na
41.64M
$ -0.18
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-18-2024 12-31-2023 10-K
2 11-14-2023 09-30-2023 10-Q
3 08-14-2023 06-30-2023 10-Q
4 05-12-2023 03-31-2023 10-Q
5 03-17-2023 12-31-2022 10-K
6 11-10-2022 09-30-2022 10-Q
7 08-15-2022 06-30-2022 10-Q
8 05-12-2022 03-31-2022 10-Q
9 03-11-2022 12-31-2021 10-K
10 11-15-2021 09-30-2021 10-Q
11 08-16-2021 06-30-2021 10-Q
12 05-14-2021 03-31-2021 10-Q
13 03-12-2021 12-31-2020 10-K
14 11-12-2020 09-30-2020 10-Q
15 08-14-2020 06-30-2020 10-Q
16 05-15-2020 03-31-2020 10-Q
17 03-30-2020 12-31-2019 10-K
18 11-14-2019 09-30-2019 10-Q
19 08-13-2019 06-30-2019 10-Q
20 05-15-2019 03-31-2019 10-Q
21 03-15-2019 12-31-2018 10-K
22 11-09-2018 09-30-2018 10-Q
23 08-14-2018 06-30-2018 10-Q
24 05-15-2018 03-31-2018 10-Q
25 04-16-2018 12-31-2017 10-K
26 11-09-2017 09-30-2017 10-Q
27 08-11-2017 06-30-2017 10-Q
28 05-12-2017 03-31-2017 10-Q
29 03-17-2017 12-31-2016 10-K
30 11-10-2016 09-30-2016 10-Q
31 08-12-2016 06-30-2016 10-Q
32 05-16-2016 03-31-2016 10-Q
33 03-30-2016 12-31-2015 10-K
34 11-12-2015 09-30-2015 10-Q
35 08-14-2015 06-30-2015 10-Q
36 05-15-2015 03-31-2015 10-Q
37 03-27-2015 12-31-2014 10-K
38 11-14-2014 09-30-2014 10-Q
39 08-14-2014 06-30-2014 10-Q
40 05-09-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-initiates-coverage-on-cyclo-therapeutics-with-buy-rating-announces-price-target-of-3
HC Wainwright & Co. Initiates Coverage On ...
05/01/2024 10:13:28

HC Wainwright & Co. analyst Swayampakula Ramakanth initiates coverage on Cyclo Therapeutics (NASDAQ:CYTH) with a Buy rat...

ascendiant-capital-initiates-coverage-on-cyclo-therapeutics-with-buy-rating-announces-price-target-of-26
Ascendiant Capital Initiates Coverage On C...
04/22/2024 09:40:07

Ascendiant Capital analyst Lucas Ward initiates coverage on Cyclo Therapeutics (NASDAQ:CYTH) with a Buy rating and announces...

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
04/18/2024 20:31:32

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
04/02/2024 20:31:04

cyclo-therapeutics-receives-decision-to-grant-european-patent-titled-methods-for-treating-alzheimers-disease-with-hp-beta-cyclodextrin
Cyclo Therapeutics Receives Decision To Gr...
04/02/2024 18:31:50

https://register.epo.org/application?number=EP19805439

cyclo-therapeutics-fy23-eps-123-up-from-183-yoy-revenue-1076m-down-from-1375m-yoy
Cyclo Therapeutics FY23 EPS $(1.23) Up Fro...
03/18/2024 13:11:41

cyclo-therapeutics-announces-issuance-of-us-patent-covering-the-use-of-trappsol-cyclo-for-the-treatment-of-alzheimers-disease
Cyclo Therapeutics Announces Issuance Of U...
03/14/2024 13:35:58

Cyclo Therapeutics, Inc. (NASDAQ:CYTH) ("Cyclo Therapeutics" or the "Company"), a clinical stage biotechnology ...

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
03/13/2024 21:32:47

cyclo-therapeutics-announces-allowance-of-patent-application-for-treatment-of-alzheimers-disease-from-uspto
Cyclo Therapeutics Announces Allowance Of ...
01/29/2024 14:15:51

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
01/15/2024 17:30:51

why-douyu-international-shares-are-trading-higher-by-14-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why DouYu International Shares Are Trading...
12/28/2023 18:07:18

Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share ...

why-bridgeline-digital-shares-are-trading-lower-by-13-here-are-20-stocks-moving-premarket
Why Bridgeline Digital Shares Are Trading ...
12/28/2023 13:22:02

Shares of Bridgeline Digital, Inc. (NASDAQ: BLIN) fell sharply in pre-market following the release of fourth-quarter results. ...

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
12/27/2023 21:31:03

cyclo-therapeutics-announced-outcome-from-its-recent-type-c-meeting-with-the-us-fda-to-discuss-full-data-review-of-trappsol-cyclo-clinical-development-program-to-date-and-proposed-strategies-for-statistical-analysis-for-phase-3-study-transportnpc
Cyclo Therapeutics, Announced Outcome From...
12/18/2023 14:20:41

Ongoing pivotal Phase 3 study ("TransportNPC™") evaluating Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease T...

cyclo-therapeutics-q3-eps-029-up-from-050-yoy-sales-45948k-beat-43000k-estimate
Cyclo Therapeutics Q3 EPS $(0.29) Up From ...
11/15/2023 13:23:17

Cyclo Therapeutics (NASDAQ:CYTH) reported quarterly losses of $(0.29) per share. This is a 42 percent increase over losses of $...

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
11/08/2023 17:31:09

cyclo-therapeutics-has-received-a-notice-of-allowance-for-its-us-patent-application-17289137-titled-methods-for-treating-alzheimers-disease
Cyclo Therapeutics Has Received A Notice O...
11/06/2023 17:14:33

https://patentcenter.uspto.gov/applications/17289137/ifw/docs

cyclo-therapeutics-announces-early-exercise-of-warrants-by-board-members-management-and-a-significant-shareholder-resulting-in-cash-proceeds-of-24m
Cyclo Therapeutics Announces Early Exercis...
10/23/2023 12:18:52

Issues New Warrants to this Investment Group for Possible Additional Funding of Up to $3.47 Million (if exercised) Cyclo Thera...

benzingas-top-ratings-upgrades-downgrades-for-september-27-2023
Benzinga's Top Ratings Upgrades, Downgrade...
09/27/2023 15:00:45

maxim-group-upgrades-cyclo-therapeutics-to-buy-announces-4-price-target
Maxim Group Upgrades Cyclo Therapeutics to...
09/27/2023 13:35:12

Maxim Group analyst Jason McCarthy upgrades Cyclo Therapeutics (NASDAQ:CYTH) from Hold to Buy and announces $4 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION